当前位置: X-MOL首页 › SCI期刊查询及投稿分析系统 › Cell Biology and Toxicology杂志
Cell Biology and Toxicology
基本信息
期刊名称 | Cell Biology and Toxicology CELL BIOL TOXICOL |
---|---|
期刊ISSN | 0742-2091 |
期刊官方网站 | https://www.springer.com/10565 |
是否OA | No |
出版商 | Springer Netherlands |
出版周期 | Bimonthly |
文章处理费 | 登录后查看 |
始发年份 | 1984 |
年文章数 | 48 |
影响因子 | 5.3(2023) scijournal影响因子 greensci影响因子 |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学2区 | CELL BIOLOGY 细胞生物学3区 | 否 | 否 |
TOXICOLOGY 毒理学2区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 9.9 | 1.649 | 1.180 |
Pharmacology, Toxicology and Pharmaceutics Toxicology |
11/133 | 92% |
|||
Environmental Science Health, Toxicology and Mutagenesis |
22/148 | 85% |
|||
Biochemistry, Genetics and Molecular Biology Cell Biology |
64/285 | 77% |
补充信息
自引率 | 1.9% |
---|---|
H-index | 56 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | 登录后查看 |
网友分享审稿时间 | 数据统计中,敬请期待。 |
接受率 | 登录后查看 |
PubMed Central (PMC) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0742-2091%5BISSN%5D |
投稿指南
期刊投稿网址 | https://submission.nature.com/new-submission/10565/3 |
---|---|
收稿范围 | Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases. SUBJECTS COVERED: 1. Gene and protein-based regulations in diseases CBT welcomes submissions in the fields of genomics and proteomic, functional genomics and proteomics, computational biology, and gene expression and function. CBT particularly includes aspects of the multifactorial genetics and epigenetics of diseases, disease-specific biomarkers, developmental biology, systems biology and bioinformatics-based data mining approaches with translational potentials. 2. Molecular pharmacology and toxicology CBT specially focuses on drug target identification and validation, rational drug design, genetic/small molecule (high-throughput) screening, novel therapeutic approaches, combinatorial and parallel synthesis of drugs, pharmacokinetics and pharmacodynamics, pharmacogenomics and toxicogenomics. 3. Pathological mechanisms related with intracellular organelles and cells CBT publishes novel findings on membrane biology and domains, and the associated receptor and non-receptor mediated signaling and transport proteins of the cell membrane, mitochondria, the endoplasmic reticulum, Golgi apparatus, and other organelles in health and disease. On the cellular and organism level, CBT aims to understanding cancer development, maintenance and treatment resistance, immune and inflammatory cell function, neuroscience, stem cell development and differentiation, epithelial biology and endothelial barrier function. 4. Biomedical aspects of organ systems in diseases CBT primarily publishes studies on the immune system, central and autonomic nervous systems, gastrointestinal system, cardiovascular and circulatory system, endocrine system, and pulmonary system, skeletal and muscular system, and urinary system to understand deeper about pathogeneses and therapies. |
收录体裁 | |
投稿指南 | https://link.springer.com/journal/10565/submission-guidelines |
投稿模板 | |
参考文献格式 | |
编辑信息 |
我要分享 (欢迎您来完善期刊的资料,分享您的实际投稿经验)